Pfizer Logo
US7170811035

Pfizer

Ins Portfolio
Kostengünstig und breit gestreut in Europa investieren. Jetzt entdecken
Anzeige

Kurse werden geladen...

Prognose

Das durchschnittliche Kursziel der Analysten beträgt +20,70(3,09%). Der Median liegt bei +20,70(3,09%).

Kaufen
  15
Halten
  21
Verkaufen
  1

Scoring-Modelle

Dividenden-Strategie13 / 15
HGI-Strategie10 / 18
Levermann-Strategie5 / 13
Powered byaktien.guide

News


  • “Nobody Ever Went Broke Taking a Profit” – Grab The Highest-Yielding S&P 500 Stocks Right Now

    A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who want to keep their money are in bonds.» Mehr auf 247wallst.com


  • Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

    Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.» Mehr auf zacks.com


  • How to Build a Low-Cost Portfolio for $5,000 Without Taking Risks

    Key Points Focus on low-priced, low-beta stocks to populate your $5,000 portfolio. Add in a few low-cost, risk-reduced ETFs for enhanced diversification. Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; get started by clicking here.(Sponsor) Investing in the 2020s isn’t exclusively for the wealthy. With as little as $5,000, you can build a low-cost portfolio with excellent growth potential for the long term. Selecting a handful of affordable stocks and low-priced exchange traded funds (ETFs) will allow you to diversify and thereby de-risk your portfolio. As we’ll see, a few simple strategies can help you turn your $5,000 into a worry-free passive income generator. Finding Affordable, Low-Risk Stocks To properly diversify your $5,000 portfolio, you’ll want to select some ETFs with baskets of stocks. However, it’s fine to start off by picking a few individual stocks. You’ll want to concentrate on large-cap blue-chip stocks representing well-known brands with good reputations. That’s the first key to de-risking your portfolio. Furthermore, you’ll need to narrow down your picks to low-priced stocks. Also, you’ll want to focus on stocks with low beta. To sum it up, beta is a measure of how fast a stock moves (in both directions, up and down) when compared to the S&P 500 large-cap stock index. The S&P 500 has a beta of exactly 1. If a stock has a beta of less than 1, then its price tends to move slower than the S&P 500. That’s a sign that the stock has low volatility and is relatively safe. 3 Low-Priced Stocks to Get You Started The best way to explain my stock picking process for a $5,000 portfolio is with a few examples. One candidate is AT&T (NYSE:T) stock, which represents a famous, well-established, and highly profitable company. As of July 9, 2025, AT&T stock cost less than $30 per share. Plus, the stock had a beta (based on the past five years’ worth of price action) of 0.6. That beta is much lower than 1, so AT&T stock tends to move substantially slower than the S&P 500. Moreover, the stock offers a forward annual dividend yield of 3.84%, which is a nice bonus for the shareholders. Another example is Coca-Cola (NYSE:KO) stock. There’s no doubt that you’ve heard of this company, and it’s been a profitable dividend payer for many years. Coca-Cola stock checks all the right boxes for a $5,000 low-risk portfolio. The stock costs around $70 per share (I’m looking for stocks below $100), has an ultra-low beta of 0.46, and offers a 2.88% annual dividend yield. Then there’s pharmaceutical giant Pfizer (NYSE:PFE), which provides its loyal investors with a massive 7.1% annual dividend yield. Given Pfizer stock’s low share price of around $25 and its beta of 0.49, this certainly looks like a strong candidate for a low-risk $5,000 investment account. De-Risk and Diversify With ETFs Even if you pick a dozen stocks for your $5,000 portfolio, that’s still not enough diversification. Therefore, you can add a few ETFs representing baskets of stocks. If they pay decent dividends, you could further enhance your profit potential. My favorite ETF pick is the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD). This fund focuses on the Dow Jones U.S. Dividend 100 Index and includes roughly 100 large-cap stocks. With an annual distribution (dividend) yield of 3.97%, the SCHD ETF will deposit cash into your $5,000 account every three months. It will also generally mitigate share-price volatility as the fund has a beta of 0.78. Next, I will refer you to Joey Frenette’s excellent article about two ETF’s under $50 which also happen to be low-risk. The first one is the Invesco S&P SmallCap Low Volatility ETF (NYSEARCA:XSLV), which has a share price below $50. Small-cap stocks can be volatile when purchased individually. However, the XSLV ETF includes hundreds of high-confidence small-cap stocks across multiple market sectors. Besides, you’ll get access to consistent dividends as XSLV has a 12-month distribution rate of 2.43%. On top of all that, the fund’s beta of 0.82 is reasonably low, which means you can sleep soundly at night if you own the Invesco S&P SmallCap Low Volatility ETF. Frenette also highlights the Invesco S&P 500 High Dividend Low Volatility ETF (NYSEARCA:SPHD), which trades for slightly less than $50 per share. SPHD’s 12-month distribution rate of 3.41% is quite respectable, and the fund provides exposure to around 50 stocks from the prestigious S&P 500 index. With a quick check, we can see that the Invesco S&P 500 High Dividend Low Volatility ETF has a fairly low beta of 0.77. By combining XSLV and SPHD, investors can achieve a balanced mix of small-caps and large-caps. Along with that, you could purchase shares of the SCHD ETF and a small selection of affordable, low-beta individual stocks. When all is said and done, your $5,000 can get you a risk-reduced low-cost portfolio to hold for many years.The post How to Build a Low-Cost Portfolio for $5,000 Without Taking Risks appeared first on 24/7 Wall St..» Mehr auf 247wallst.com

Dividenden

Alle Kennzahlen
In 2025 hat Pfizer bereits +0,77 Dividende ausgeschüttet. Die letzte Dividende wurde im Juni gezahlt.

Unternehmenszahlen

Im letzten Quartal hatte Pfizer einen Umsatz von +12,60 Mrd und ein Nettoeinkommen von +2,73 Mrd
(EUR)März 2025
YOY
Umsatz+12,60 Mrd8,61%
Bruttoeinkommen+9,99 Mrd2,66%
Nettoeinkommen+2,73 Mrd5,57%
EBITDA+4,65 Mrd15,71%

Fundamentaldaten

MetrikWert
Marktkapitalisierung
+125,76 Mrd
Anzahl Aktien
5,69 Mrd
52 Wochen-Hoch/Tief
+27,20 - +18,04
Dividendenrendite
+7,29%
Dividenden TTM
+1,55
Beta
0,49
KGV (PE Ratio)
+18,51
KGWV (PEG Ratio)
8,70
KBV (PB Ratio)
+1,61
KUV (PS Ratio)
+2,33

Unternehmensprofil

Pfizer Inc. erforscht, entwickelt, produziert, vermarktet, vertreibt und verkauft weltweit biopharmazeutische Produkte. Das Unternehmen bietet Medikamente und Impfstoffe in verschiedenen therapeutischen Bereichen an, darunter Herz-Kreislauf-Stoffwechsel- und Frauengesundheit unter den Marken Premarin und Eliquis; Biologika, kleine Moleküle, Immuntherapien und Biosimilars unter den Marken Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena und Braftovi; und sterile injizierbare und antiinfektiöse Arzneimittel sowie orale COVID-19-Behandlung unter den Marken Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga und Paxlovid. Das Unternehmen bietet auch Arzneimittel und Impfstoffe in verschiedenen therapeutischen Bereichen an, wie Pneumokokken, Meningokokken, Zeckenenzephalitis und COVID-19 unter den Marken Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba und der Prevnar-Familie; Biosimilars für chronische Immun- und Entzündungskrankheiten unter den Marken Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis und Cibinqo sowie Amyloidose, Hämophilie und endokrine Erkrankungen unter den Marken Vyndaqel/Vyndamax, BeneFIX und Genotropin. Darüber hinaus ist das Unternehmen im Bereich der Auftragsherstellung tätig. Das Unternehmen beliefert Großhändler, Einzelhändler, Krankenhäuser, Kliniken, Behörden, Apotheken und einzelne Anbieter sowie Zentren für Krankheitskontrolle und Prävention. Das Unternehmen hat Kooperationsvereinbarungen mit Bristol-Myers Squibb Company, Astellas Pharma US, Inc, Myovant Sciences Ltd, Akcea Therapeutics, Inc, Merck KGaA, Valneva SE, BioNTech SE und Arvinas, Inc. Pfizer Inc. wurde 1849 gegründet und hat seinen Hauptsitz in New York, New York.

Name
Pfizer
CEO
Albert Bourla
SitzNew York City, ny
USA
Website
Industrie
Pharmazie
Börsengang
Mitarbeiter81.000

Ticker Symbole

BörseSymbol
NYSE
PFE
XETRA
PFE.DE
XETRA
PFE.F
Frankfurt
PFE.F
Düsseldorf
PFE.DU
Hamburg
PFE.HM
Milan
1PFE.MI
London
0Q1N.L
SIX
PFE.SW
München
PFE.MU
Wien
PFE.VI
🍪

Parqet nutzt Cookies.Erfahre Mehr